Evidence map›Paper›PMID 40275231›Full record

ArticleBMC nephrology2025

Morphological transition after medical treatment of emphysematous pyelonephritis over time-case report.

Ukyo Yamamoto, Motoka Yagame, Daisuke Uchida, Masumi Hara, Hideyuki Takeuchi, Hiroo Kawarazaki

Abstract readCase Reports
In one paragraph

Article in BMC nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ukyo YamamotoDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan. aoo880088ooa@gmail.com.
Motoka YagameDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan.
Daisuke UchidaDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan.
Masumi HaraDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan.
Hideyuki TakeuchiDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan.
Hiroo KawarazakiDepartment of Internal Medicine, Teikyo University Hospital Mizonokuchi, Kawasaki, Japan. hirookawarazaki@yahoo.co.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmphysematous pyelonephritis (EPN) is a necrotizing infection characterized by the production of gas in the renal parenchyma, collecting system or perirenal tissue. The treatment strategy, especially for surgical intervention, in EPN has been based on the Huang and Wan classifications. Huang's classification is based on the extent of gas and abscess spillover, while Wan's classification is based on the morphology of gas and fluid retention. Wan's classification type I EPN is considered more severe compared to type II EPN and pathophisyological mechanisms are speculated as the cause of the different presentation but the actual cause is unknown. In the present case, conservative treatment of EPN in the early stages of the disease allowed us to show that Wan's classification may represent a time series of morphologic changes throughout EPN. CASE PRESENTATION: A 72-year-old woman treated for diabetes was admitted because of suspected treatment-resistant pyelonephritis. Her CT scan at presentation was suggestive of EPN and antibiotics was started. After additional medical treatment, a follow-up of CT image showed that the initial appearance of bubbly gas formation changed into a fluid-forming abscess. This transition shows that type I is an early phase image of EPN and type II image is seen following the early phase. Thereafter no change was seen in CT image and residing inflammation led to planned nephrectomy on day 35. Antibiotics were discontinued and no recurrence was confirmed.

conclusionsWan's type I and II EPN has been often reported as different pathophysiological entities. Our case shows that these two subtypes may represent stages in the progression of EPN. Medical treatment for type I may permit safe nephrectomy for type II EPN.

Indexed as

Anti-Bacterial AgentsEmphysemaPyelonephritisAgedEmphysematous PyelonephritisFemaleHumansTomography, X-Ray ComputedAnti-Bacterial AgentsChanges in gas imageComputed tomographyEmphysematous pyelonephritisType2 diabetesX-ray image

Identifiers

PMID40275231
PMCPMC12023580

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.